Nottingham Prognostic Index Plus (NPI+): a modern clinical decision making tool in breast cancer

por Rakha, E A, Soria, D, Green, A R, Lemetre, C, Powe, D G, Nolan, C C, Garibaldi, J M, Ball, G, Ellis, I O
Publicado 2014

Biology of primary breast cancer in older women treated by surgery: with correlation with long-term clinical outcome and comparison with their younger counterparts

por Syed, B M, Green, A R, Paish, E C, Soria, D, Garibaldi, J, Morgan, L, Morgan, D A L, Ellis, I O, Cheung, K L
Publicado 2013

Identification of key clinical phenotypes of breast cancer using a reduced panel of protein biomarkers

por Green, A R, Powe, D G, Rakha, E A, Soria, D, Lemetre, C, Nolan, C C, Barros, F F T, Macmillan, R D, Garibaldi, J M, Ball, G R, Ellis, I O
Publicado 2013

Nottingham prognostic index plus (NPI+) predicts risk of distant metastases in primary breast cancer

por Green, Andrew R., Soria, D., Powe, D. G., Nolan, C. C., Aleskandarany, M., Szász, M. A., Tőkés, A. M., Ball, G. R., Garibaldi, J. M., Rakha, E. A., Kulka, J., Ellis, I. O.
Publicado 2016